Answers are grounded in this paper and cite their sources.
Essential thrombocythemia represents a rare risk factor for ischemic stroke. Uncontrolled proliferation of megakaryocytes sustained increases circulating platelet count and thrombotic risk. Many patients suffering from the disease may have no symptoms for a long time. We present a case of 60 year old lady with ischemic stroke who was a known case of essential thrombocythemia. And the cerebrovascular event was the complication of essential thrombocythemia as she quit treatment. J MEDICINE 2022; 23: 169-172
No takes yet. Share an insight, caveat, or question.
Moniruzzaman et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: